Pertinent Positive Pertinent Negative Weight Loss (41 KG To 37 KG in 1-2 Months) Productive Cough Double Vision Lymph Node Swelling Fatigue Bruising Syncope Body Tremors Dyspnea
TD 1st For pregnant women after detections of 0.5 ml IM
Diphtheria, tetanus, pregnancy as early as possible TD 2nd After 1 month of 1st dose 0.5 ml IM Diphtheria, tetanus, BCG At Birth or as early as possible till one year 0.1 ml ID tuberculosis (TB) of age Hepatitis B At Birth; or as early as possible before 24 0.5 ml IM Hepatitis B virus hours OPV-O At Birth; or as early as possible before 15 2 drops ORAL Polio Days OPV 1,2 & 3 At 6 weeks,10 weeks, & 14 weeks 2 drops ORAL Polio Pentavalent At 6 weeks,10 weeks, & 14 weeks 0.5 ml IM Diphtheria, tetanus, 1,2 & 3 pertussis, Hep-B & Hib PCV 1st, 3rd & 9th month 0.5 ml IM Pneumococcal infection Rotavirus At 6 weeks,10 weeks, & 14 weeks 5 drops ORAL Rotavirus diarrhea (and vomiting) IPV (Polio 2 fractional dose 6 & 14 weeks of age 0.1 ml ID Polio MR 1st Dose 9-12 months 0.5 ml SC Measles & Rubella
JENVAC-1 9-12 months 0.5 ml SC Japanese Encephalitis
Vit-A 1st Dose 9 completed Month 1 lakh IU ORAL Night blindness DPT Boster-2 16-24 months 0.5 ml IM Diphtheria, tetanus, pertussis MR 2nd Dose 16-24 months 0.5 ml SC Measles & Rubella OPV Boster 16-24 months 2 drops ORAL Polio JENVAC-2 16-24 months 0.5 ml SC Japanese Encephalitis Vit-A 2nd to 9th 16-18 month then 6-month interval 2lakh IU ORAL Night blindness Dose DPT Boster-1 5-6 years 0.5 ml IM Diphtheria, tetanus, pertussis TD 10 -16 years 0.5 ml IM Diphtheria, tetanus, IMMUNIZADION SCHEDULE
Pertinent Positive Pertinent Negative Weight Loss (41 KG To 37 KG in 1-2 Months) Productive Cough Double Vision Lymph Node Swelling Fatigue Bruising Syncope Body Tremors Dyspnea